Stay updated with breaking news from Psychedelic Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the
The FDA is expected to make its final decision by August
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream.
Federal health advisers are rejecting the first-ever proposal to use MDMA as a treatment for PTSD
FDA advisors cited concerns over clinical data, selection and expectation bias, and the safety risks of MDMA.